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Abstract
Background: Medical and pre-professional health students ask questions about human health that
can be answered in two ways, by giving proximate and evolutionary explanations. Proximate
explanations, most common in textbooks and classes, describe the immediate scientifically known
biological mechanisms of anatomical characteristics or physiological processes. These explanations
are necessary but insufficient. They can be complemented with evolutionary explanations that
describe the evolutionary processes and principles that have resulted in human biology we study
today. The main goal of the science of Darwinian Medicine is to investigate human disease,
disorders, and medical complications from an evolutionary perspective.
Discussion: This paper contrasts the differences between these two types of explanations by
describing principles of natural selection that underlie medical questions. Thus, why is human birth
complicated? Why does sickle cell anemia exist? Why do we show symptoms like fever, diarrhea,
and coughing when we have infection? Why do we suffer from ubiquitous age-related diseases like
arteriosclerosis, Alzheimer's and others? Why are chronic diseases like type II diabetes and obesity
so prevalent in modern society? Why hasn't natural selection eliminated the genes that cause
common genetic diseases like hemochromatosis, cystic fibrosis, Tay sachs, PKU and others?
Summary: In giving students evolutionary explanations professors should underscore principles
of natural selection, since these can be generalized for the analysis of many medical questions. From
a research perspective, natural selection seems central to leading hypotheses of obesity and type
II diabetes and might very well explain the occurrence of certain common genetic diseases like
cystic fibrosis, hemochromatosis, Tay sachs, Fragile X syndrome, G6PD and others because of their
compensating advantages. Furthermore, armed with evolutionary explanations, health care
professionals can bring practical benefits to patients by treating their symptoms of infection more
specifically and judiciously. They might also help curtail the evolutionary arms race between
pathogens and antibiotic defenses.
Background
The science of Darwinian or Evolutionary Medicine was
formalized in the early 1990s most notably by the emi-
nent evolutionary biologist George C. Williams and the
physician and professor Randolph Nesse [1,2]. Its meth-
odologies and aims are directed at the scientific
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investigation of evolutionary causes for human disease, dis-
orders, malfunctions and apparent design failures in order
to improve health care and to stimulate fruitful research
directions.
To clarify what we mean by evolutionary causes it is useful
to make a distinction from a different level of causality in
biology, that of proximate causes. Proximate causes are at
the level of the immediate mechanisms that give rise to
disease, disorders, and malfunctions. These include
detailed accounts of physiological processes, embryologi-
cal development, and anatomical relationships and
functions.
Evolutionary explanations, in contrast, are obtained via
researchers taking an historical perspective (see Mayr [3]).
They look back in time, through lenses of scientifically
established evolutionary principles, in order to investigate
medical problems and ailments. An evolutionary
approach would ask such questions as: "Why hasn't natu-
ral selection eliminated a particular disease?" "Why do
our bodies have certain flaws of engineering that make us
susceptible to particular medical complications?" "Might
certain modern diseases and ailments be the result of a
mismatch between our biological heritage and our mod-
ern-day lifestyles?" and "Are characteristic physiological
responses to disease in fact adaptive defenses that have
developed over evolutionary time?"
Neither approach, proximate or evolutionary, can be
ignored. In fact, such explanations should in theory feed-
back positively to stimulate novel research approaches
[2]. Nonetheless, we realize that evolutionary explana-
tions may seem foreign to many persons in the medical
field. After all, most of modern day medicine is based on
scientifically discovered proximate explanations, and
these explanations dominate in medical textbooks. Thus,
to illustrate the evolutionary perspective, in this paper we
give a variety of examples for which evolutionary explana-
tions are known or hypothesized. We also describe the
theoretical evolutionary principles that underpin these
examples and that can be generalized to the investigation
of many medical questions.
Complications of human child-birth: proximate causes
Many of our students are perplexed when they hear about
the pain accompanying child delivery. They wonder "Why
is there so much pain?" and "Why is the birthing process
such a complication, so much so that many doctors
deliver by Caesarean section?" The proximate answer
describes that the diameter of the human fetus's head is
very large (the widest part of the fetus) and the diameter
of pelvic outlet of the mother is only slightly bigger. This
makes it a very tight passage for the fetus, a very painful
process for the mother, and a complicated process for the
obstetrician to manage. The release of the hormone
relaxin during pregnancy (a proximate mechanism) helps
to loosen the pubic symphysis and dilate the uterine cer-
vix easing the complication to a degree. It is easier all
around, even if not always necessary, if the fetus can
detour the natural route and be delivered through an
alternate passageway created in the mother's lower
abdomen.
Being accustomed to such explanations, many students
appear satisfied, though this is likely a cover up. Curious
students naturally want further explanation, "But why is a
human infant's head so big?" "Why isn't the mother's
birth canal larger? And finally "Why is the human birthing
process so complicated? These questions have evolution-
ary explanations – explanations that may only rarely
emerge in medical and health profession's classes.
Complications of human child-birth: evolutionary causes
Following is a classic evolutionary explanation backed by
considerable paleoanthropological evidence. Beginning
about 2.5 million years ago, the evolutionary lineage lead-
ing to modern humans shows a trend towards increasing
brain size so that by around 500,000 years ago our ances-
tors had brains (and crania) about as large as they are
today [4]. However, despite the advantages, evolving such
large brains posed serious problems for mothers who
need to pass their infant's head through a relatively small
pelvic canal [4,5].
"But if brain size evolved to its modern size so long ago,
why hasn't evolution had enough time to fix the imperfect-
fit... that is, why isn't the birth canal larger?" Well, females
have indeed evolved a rounder pelvic opening to facilitate
the uneasy passage of the newborn's head. This explains
the anatomical differences we observe between male and
female pelves. There is, however, a limit to the degree to
which the female pelvic opening can enlarge. This con-
straint arises because of another unique human adapta-
tion namely bipedalism – walking on two legs.
Exceptional increase of the birth canal would require
repositioning of the gluteal pelvic-abductors in such a way
as to make bipedalism mechanically and energetically
inefficient. Thus, the overall size of the birth canal can be
viewed as an evolutionary compromise between two
advantageous features of human evolution – increased
brain size as well as the new style of locomotion. These
two different evolutionary pressures have led to the diffi-
cult and imperfect process of human child birth [4,5]. (For
further discussion of evolutionary obstetrics see Tra-
vathan's book Evolutionary Medicine [6]).
The example of sickle cell disease: a proximate perspective
Take as another example, sickle cell anemia. A student
asks, "Why does sickle cell disease exist?" The proximateBMC Medical Education 2005, 5:16 http://www.biomedcentral.com/1472-6920/5/16
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(or mechanistic) explanation is necessary but not suffi-
cient. A point mutation at the sixth amino acid position of
the β  hemoglobin chain replaces glutamic acid with valine
and produces the so-called abnormal hemoglobin type
HbS (the normal type is HbA). When a cell having only the
HbS type gives up oxygen to body tissues it loses the nor-
mal red blood cell shape (symmetrical biconcave) and
becomes crescent or sickle-shaped. These homozygous
individuals (HbS/HbS) develop sickle cell disease in which
sickle-shaped RBCs block small peripheral blood vessels
leading to very serious secondary effects. Without regular
medical intervention few persons live to adulthood [7].
Promisingly, with the recent development of modern
treatment regimens (e.g. stem cell transplantations, serial
blood transfusions, and prophylactic treatments with
penicillin) patients show increased survivability, living
into their 40s and 50s and in some cases even older [8,9].
Unfortunately, many children with sickle cell disease do
not have access to intensive treatment programs, either
because it is not locally available or their health insurance
plans limit access to it [10].
Many of our students are older students and have worked
in hospitals or clinics in the New York City area. Most are
aware that sickle cell disease is commonly encountered.
On average, 1 in every 600 births in the African-American
population is to a baby with sickle cell disease [11]. There-
fore, these students will wonder, "If sickle cell disease is so
lethal, then why hasn't it been eliminated?"
Sickle cell disease: an evolutionary perspective
An evolutionary explanation is that sickle cell anemia is
an example of a disease caused by a gene that can also be
beneficial. The HbS type is found at high frequencies (up
to 20% and above) in much of tropical Africa. In most
other parts of the world the frequency is very low (<1% or
absent), excepting for regions such as the Mediterranean,
the Arabian Peninsula, and the Americas where a high fre-
quency is due to historic migration and admixture [7].
Importantly, within Africa the distribution of the (HbS)
almost exactly matches the distribution of the mosquito-
transmitted disease known as malaria, caused by the par-
asite Plasmodium falciparum. It is known that heterozy-
gotes (HbS/HbA), having both types of hemoglobin (and
who have only minor health problems), show resistance
to malarial infection because the body targets the P. falci-
parum infected cells for destruction. In contrast, individu-
als homozygous for normal hemoglobin (HbA/HbA)
suffer high mortality rates in early childhood due to
malarial infection. Thus, the allele for sickle cell has been
maintained because heterozygotes have a higher repro-
ductive success than either of the two possible homozy-
gotes. The evolutionary process explaining the
phenomenon is known as balancing selection, a special
form of natural selection that operates to keep two or
more beneficial alleles at relatively high frequencies [7].
This classic example is known since the 1950s [12] and
the relationships between mosquito ecology, agriculture,
malaria, and frequencies of the sickle cell gene have been
carefully studied [13]. Notwithstanding our knowledge,
clear explanations of the evolutionary processes that
underlie sickle-cell disease, balancing selection and heterozy-
gote advantage, are still not found in many medical and
pre-professional health texts leaving students needlessly
wondering 'Why?' Indeed, understanding these evolution-
ary processes would help students understand why genes
underlying other hemotological disorders like alpha and
beta thalassemias, Hemoglobin E (Hb E) syndrome, and
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
are found at high frequencies in certain populations from
the Mediterranean, African and/or South East Asia
[14,15]. Like with sickle cell, evidence suggests that natu-
ral selection has maintained these disease genes because
they too confer resistance to malaria [14,15]. While these
diseases were once geographically confined, they are now,
due to forced, historic, or recent emigration, seen com-
monly in US or European hospitals and clinics. For exam-
ple, Glader and Look [16] report that 41% of the South
East Asian refugee population in the United States are car-
riers of, or have, one of the myriad hematological disor-
ders. While in past decades it may have been rare for our
students to come into contact with these diseases; today
the likelihood is much greater.
Explaining symptoms
Evolutionary causes can also explain classic symptoms of
illness. Traditionally, we teach that symptoms like fever,
inflammation, diarrhea, coughing, vomiting are problems
that need to be alleviated by medication. The proximate
mechanisms of these symptoms are described in most
textbooks. Not sufficiently discussed, though, are evolu-
tionary explanations. These explanations derive from the
ongoing evolutionary arms race between pathogens and
us, each one trying to out-perform the other. Therefore, to
what extent are so-called "symptoms" the body's way of
defending itself, and to what extent are they manipula-
tions by the pathogen, "intended" to increase its repro-
duction and spread?
Studies suggest that fever is an evolved defense mecha-
nism against pathogens that if reduced by medicinal drugs
can, in some cases, prolong illness and cause secondary
infections [1,2,17]. Diarrhea has been hypothesized to be
either a defense mechanism or a manipulation by the
pathogen, or even both simultaneously [17]. Persons with
Shigella bacteria develop severe bloody diarrhea. To test
the diarrhea-as-defense hypothesis persons were treated
with and without the anti-diarrhea medication Lomotil™.BMC Medical Education 2005, 5:16 http://www.biomedcentral.com/1472-6920/5/16
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Results showed that illness was prolonged in the treated
group as compared with the untreated group [18]. In con-
trast, Vibrio cholerae, the bacterium that causes cholera,
carries a toxin on its cell membrane that induces diarrhea,
presumably to help its spread. Infected people are severely
affected and at risk for death due to loss of body fluids. In
this case, treatment with anti-diarrhea medication may
counter the pathogens strategy and aid against dehydra-
tion and against spread of the bacteria [17]. Ideally, the
physician would want to know when defenses are useful
to the patient and when they are manipulations by path-
ogens [1,17]. If each pathogen-host combination were to
be analyzed separately, realizing that the balance of evo-
lutionary forces acting on the host and pathogen may vary
in each case, then treatment would likely become more
specific and effective.
Discussion
Evolutionary explanations & natural selection
Can our students benefit from such evolutionary explana-
tions? Yes, we believe they can. In fact, this is the central
tenet of the science of Evolutionary Medicine: that princi-
ples of evolutionary theory can provide a unifying princi-
ple by which human biology, disease, and disorders can
be understood [1,2]. The explanatory power lies in fully
understanding how natural selection operates.
Following we explain several important principles of nat-
ural selection that are generally applicable to understand-
ing human biology in health and disease (Table 1, and see
[1,2]).
• Natural selection cannot build perfect designs because of com-
promises that exist between different adaptations (e.g. a pelvic
girdle designed for bipedal locomotion versus one
designed to facilitate passage of a large brained infant).
Almost every human structure and physiological process
can be analyzed in terms of compromises between costs
and benefits. For example, building bones that will resist
fracture would require further increasing their thickness
and/or calcium content, though doing so would make us
slower and take away calcium crucial for normal cellular
functions. Indeed, a homeostatic mechanism has evolved
that draws calcium from bones when cellular functions
need it. However, that same mechanism can sometimes
overdraw the mineral producing problems such as frac-
ture, osteomalacia, and rickets.
• Natural selection works within the limitations imposed by the
human body's long evolutionary legacy. George C. Williams
has rhetorically questioned: why hasn't the birth canal
evolved to open through the lower abdomen rather than
through the pelvis, thus releasing the severe evolutionary
constraint against further increase in brain size? The
answer is simply that vertebrates set upon routing the
female reproductive tract through the pelvic opening hun-
dreds of millions of years ago and there has been no way
for evolutionary processes to readjust the route [19].
• Natural selection may often adapt our genes to the context of
a particular environment. Therefore, certain genotypic traits
offer benefits only with respect to the environment in
which they evolved (e.g. genes causing sickle cell disease
and other hemoglobinopathies). When these genotypes
are expressed in other environments, like sickle cell is in
the United States, there is essentially no benefit because
malaria is largely absent. As expected, the frequency of the
sickle cell gene is declining among American Blacks [7]. As
another example, in 1987 Rotter and Diamond [20]
hypothesized that the high frequency of the genes causing
Tay sachs (homozygote frequency of 1 in 6000 births) and
cystic fibrosis (homozygote frequency of 1 in 1700
births), in individuals descended from Ashkenazi Jews
and European populations respectively, results from the
survival advantage the genes conferred to heterozygote
individuals who endured past epidemics of tuberculosis
and/or typhus.
Such evolutionary hypotheses can be tested scientifically,
for example, witness studies of cystic fibrosis (CFTR)
[21,22]. The gene was recently found to code for chloride
ion protein-channels on somatic epithelial cell mem-
Table 1: Principles of natural selection generally applicable to understanding human biology in health and disease.
Natural selection:
• cannot build perfect designs because it compromises between different adaptations – bipedal walking vs. large brain size.
• will maintain a disease gene if it confers an advantage in a particular environment – sickle cell disease, alpha- & beta-thalassemia, Hb E syndrome, 
G6PD deficiency, Tay-sachs, cystic fibrosis.
• has shaped many human genes to ancient lifestyles (i.e. a hunter-gathering versus modern life-way) explaining chronic diseases like obesity, and 
type II diabetes.
• favors genes maximizing reproduction even if they compromise health (PKU, hemochromatosis, fragile X syndrome etc.) or longevity 
(Alzheimer's, atherosclerosis, prostate hyperplasia)
• explains the "arms race" between pathogens and us. We have evolved defenses both natural – fever, diarrhea, vomiting, inflammation – and 
manufactured – antibiotics. Pathogens evolve counterstrategies like antibiotic resistance, and manipulation of our defenses for their spread.BMC Medical Education 2005, 5:16 http://www.biomedcentral.com/1472-6920/5/16
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branes, and the bacteria causing typhoid fever, Salmonella
enterica serovar Typhi, was found to target the CFTR pro-
tein in GI cells to gain entry to them. Subsequent tests
showed that serovar Typhi invasion rates in mice are
reduced by over 80% in heterozygotes for the mutant
allele (∆ F508 CFTR) compared to homozygotes (for the
normal CFTR allele) due to reduced CFTR expressed on
the cell surface. Moreover, when European populations
were analyzed that reportedly suffered Typhoid scourges
in the past, it was found that they showed higher frequen-
cies for the mutated allele one to two generations after the
scourge [22]. Together, the proximate and historical evi-
dence strongly support Typhoid fever as an important
selective agent (though perhaps not the only agent) that
drove cystic fibrosis frequencies upwards due to heterozy-
gote advantage. In contrast, it is unfortunate that the Tay
sachs selective hypothesis remains largely untested almost
two decades later.
• As an extension of the previous principle, natural selec-
tion has likely optimized most of our genes to the environment
and lifestyle by which we have lived the longest – a hunter-gath-
erer lifestyle – likely explaining the presence of certain
chronic diseases (type II diabetes, obesity and others).
Our genes and homeostatic mechanisms evolved under
vastly different environmental and nutritional conditions
than those under which we live today [23-25]. For exam-
ple, with respect to obesity, much recent research has
focused on leptin, a hormone released by adipose tissue
that regulates appetite by acting on the hypothalamus.
Although further research is required, evidence suggests
that under increasingly obese body conditions the brain
becomes resistant to leptin throwing the leptin-hypotha-
lamic homeostatic system into an unhealthy positive feed-
back loop that further stimulates appetite [26,27]. With
respect to modern diets and lifestyles – high in calories
and low in physical activity – the advantage of such a sys-
tem makes little sense. However, under presumed ancient
lifestyles, in which caloric intake almost balanced caloric
consumption, the advantage of such a "thrifty genotype"
becomes clearer especially if it helped our ancestors sur-
vive intermittent episodes when food was sparse [26-28].
• Natural selection operates to maximize the number and sur-
vival of one's offspring (and thereby one's genes) in the next
generation and not to maximize health or longevity. Regarding
longevity, dramatic examples of this principle are seen in
many insects in which aging and death is swift or almost
immediate after mating. In humans, it seems to account
for the process of human senescence – the general deteri-
oration of the body with age and the rather sharp up-turn
in chronic diseases in post-reproductive years. Natural
selection selects genes on the basis of the benefits they
provide early in life even if they may cause adverse effects
later on, a concept known as antagonistic pleiotropy
[1,29](i.e. a gene having multiple but antagonistic
effects). For example, an efficient mechanism of calcium
deposition evolved to repair bone fractures early in life
may lead to arteriosclerosis, excessive calcium build-up in
arterial walls, later in life [1,29]. Unfortunately, the con-
cept of antagonistic pleiotropy (and this possible example
of it) advanced by George C. Williams in 1957 [29], has
never been rigorously tested. Nonetheless, the concept has
been recently applied in attempts to explain Alzheimer's
disease, prostate hyperplasia, and certain types of cancer
[30]. Regarding Alzheimer's disease, a recently advanced
evolutionary hypothesis [31,32] is built on findings of
neuroprotective functions for estrogen and apolipopro-
teins E2 and E3. As estrogen declines in post-menopausal
women, these apolipoproteins (uniquely evolved in
humans) help delay the onset of Alzheimer's-like pathol-
ogies (and interestingly cardiovascular disease). With lon-
gevity increases over time in the human evolutionary
lineage, older women having the neuroprotective apoli-
poproteins would have enjoyed a selective advantage
since their ability to competently care for their grandchil-
dren (with whom they share 1/4 of their DNA) was pro-
longed [31,32]. This special form of natural selection, in
which a person gains a benefit by helping close relatives,
is termed kin selection [1,33]. This hypothesis of the evolu-
tion of Alzheimer's has generated much commentary and
many scientifically testable predictions (see [31] and asso-
ciated commentaries).
Furthermore, the principle that natural selection pro-
motes reproductive success and not necessarily health
seems to explain the maintenance of certain common dis-
ease genes because of possible compensating advantages.
Following are several examples. Homozygotes for phe-
nylketonuria (PKU; frequency of 1 in 10,000 Caucasian
births) develop mental retardation because they cannot
metabolize the amino acid phenylalanine, but heterozy-
gote infants seem to show decreased probability of being
miscarried. Hemochromatosis is a very common auto-
somal recessive disease in individuals of Northern Euro-
pean descent (homozygote frequency of 1 in 200 births)
characterized by increased intestinal iron absorption. It
has been hypothesized that the gene may be advantageous
to women by compensating for high iron losses (through
menstruation, pregnancy, and milk production.) [20] On
the other hand, men with the gene may suffer from exces-
sive iron stores late in life. Supporting evidence may be
seen in the recent finding of increased longevity of female
carriers over non-carriers [34] and recent population
genetic analyses of SNPs that have revealed positive natu-
ral selection in the gene's history [35]. More recently, a dif-
ferent hypothesis has been advanced based on the finding
that individuals bearing the hemochromatosis mutation
(C282Y) show partial resistance to Yersinia, the bacterium
causing plague [36]. In normal individuals, Yersinia ini-BMC Medical Education 2005, 5:16 http://www.biomedcentral.com/1472-6920/5/16
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tially multiply within iron-rich macrophages, however
this does not occur in persons with C282Y because their
macrophages lack iron, a mineral essential for the patho-
gen's survival. This evolutionary hypothesis, which
requires further testing, suggests that natural selection
favored persons bearing the C282Y allele during the dev-
astating plague that ravaged Europe during the Middle-
ages [36].
Compensating advantages may also maintain disease
genes associated with diabetes Type I (reduced miscar-
riage when linked to the beneficial HLA DR3 gene [1,20]),
Fragile X syndrome (increased fertility among hetero-
zygous females [37] or prenatal advantages to offspring
[38]), gout and hyperuricemia (beneficial antioxidant
effects [39,40]) among other examples [1,2,6,20]. Surpris-
ingly, many such evolutionary hypotheses initially
advanced a decade or more ago on the bases of observed
biased inheritance patterns, or because of the common-
ness of the disorder and other circumstantial evidence,
have not received rigorous scientific testing. In fact, for
each disease or disorder, predictions could be made with
respect to its association with a hypothesized compensat-
ing advantage, and experiments designed to test the pre-
dictions. It would then be possible to determine the
validity of the evolutionary hypotheses, and to clarify the
proximate genetic and physiological mechanisms
involved.
Summary
We have described different aspects of human biology of
medical significance. All have evolutionary explanations
rooted in evolutionary theory. There are, of course, many
more such explanations that can be incorporated into our
texts and into medical curricula [1,2,6]. We recommend
Nesse and William's thought-provoking book on this sub-
ject as a good and comprehensive introduction to the field
[1]. Indeed, summaries of topics exist that could serve as
syllabi for medical courses [41-43]. If we can help answer
our student's questions by providing them with evolu-
tionary answers (to the extent possible given the field's
current knowledge) and by sufficiently describing evolu-
tionary principles, we will do them a large favor. They will
gain a powerful set of organizing principles around which
they can arrange the enormous amounts of proximate
information they must learn.
Furthermore, those of our students who in the future will
do basic and clinical research may indeed find it fruitful to
apply evolutionary theory and methods in order to under-
stand problems of medical interest. Evolutionary medi-
cine can have enormous potential. For example, one
recent evolutionary analysis identified genes that in the
past seem to have enabled viruses in the smallpox and
vaccinia family to evade our defenses, genes that could be
targeted for drug design today [44]. Furthermore, as
described above leading hypotheses of the origins of type
II diabetes [27,45], and obesity [26,27] have evolutionary
explanations at their cores.
As a parting thought, imagine that the questions our stu-
dents ask are like the endless series of "why" questions
children ask, that go on (and on and on)! Such questions
are also like their answers. They cycle on in a positive feed-
back loop yielding greater illumination. Although it is cru-
cial we study the proximate mechanisms of disease,
evolutionary theory offers a scientific methodology that
can lead us to examine these mechanisms in novel ways.
If we do not give our students support in asking such ques-
tions, might they stop asking them? What would be the
consequences of this? Finally, as food for thought, we ask
you to consider the following question: are you answering
your students' "why" questions?
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